Sanofi Considers Sale of Nutrition and Vitamin Business in India

On April 26, media reports cited informed sources as saying that Sanofi’s Indian subsidiary is in advanced negotiations to sell part of its over-the-counter (OTC) pharmaceutical business.

Sanofi’s India unit is reportedly considering the sale of its nutrition and vitamins business, with an estimated valuation of ₹6 billion. Piramal Enterprises Ltd is currently conducting due diligence, while Dr Reddy’s Laboratories has also expressed interest in the deal.

A spokesperson for Piramal Enterprises declined to comment, and neither Sanofi nor Dr. Reddy’s Laboratories provided a response.